| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer
|
Masuda, N.
|
|
2014
|
74 |
2 |
p. 229-238
|
article
|
| 2 |
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
|
Ahn, Hee Kyung
|
|
2014
|
74 |
2 |
p. 277-282
|
article
|
| 3 |
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies
|
Wang-Gillam, Andrea
|
|
2014
|
74 |
2 |
p. 419-426
|
article
|
| 4 |
Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression
|
Wang, Zhuo
|
|
2014
|
74 |
2 |
p. 239-247
|
article
|
| 5 |
Circulating biomarkers in hepatocellular carcinoma
|
Morris, Karen L.
|
|
2014
|
74 |
2 |
p. 323-332
|
article
|
| 6 |
Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. colil-asparaginase preparation (MC0609) in Beagle dog
|
Borghorst, Stephan
|
|
2014
|
74 |
2 |
p. 367-378
|
article
|
| 7 |
Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity
|
Ishiguro, Hitoshi
|
|
2014
|
74 |
2 |
p. 249-255
|
article
|
| 8 |
Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia
|
Zhang, Bingnan
|
|
2014
|
74 |
2 |
p. 303-307
|
article
|
| 9 |
Evaluation of pharmacokinetics and safety of ponatinib in subjects with chronic hepatic impairment and matched healthy subjects
|
Narasimhan, Narayana I.
|
|
2014
|
74 |
2 |
p. 341-348
|
article
|
| 10 |
Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers
|
Shaik, M. Naveed
|
|
2014
|
74 |
2 |
p. 411-418
|
article
|
| 11 |
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
|
Katopodis, O.
|
|
2014
|
74 |
2 |
p. 333-340
|
article
|
| 12 |
Gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure!
|
Marrelli, Daniele
|
|
2014
|
74 |
2 |
p. 433-434
|
article
|
| 13 |
Gastric cancer with para-aortic lymph nodes metastasis: curable dissection possible but be cautiously selected
|
Liu, Tianshu
|
|
2014
|
74 |
2 |
p. 435-436
|
article
|
| 14 |
Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer
|
Cao, Jun
|
|
2014
|
74 |
2 |
p. 389-398
|
article
|
| 15 |
Impact of patient ethnicity on the metabolic and immunologic effects of PI3K–mTOR pathway inhibition in patients with solid tumor malignancies
|
Aggarwal, Rahul
|
|
2014
|
74 |
2 |
p. 359-365
|
article
|
| 16 |
Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia
|
Wang, Shu-mei
|
|
2014
|
74 |
2 |
p. 283-289
|
article
|
| 17 |
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia
|
Radujkovic, Aleksandar
|
|
2014
|
74 |
2 |
p. 427-432
|
article
|
| 18 |
Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine
|
Thottassery, Jaideep V.
|
|
2014
|
74 |
2 |
p. 291-302
|
article
|
| 19 |
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment
|
Schnell, David
|
|
2014
|
74 |
2 |
p. 267-275
|
article
|
| 20 |
Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors
|
Plummer, Ruth
|
|
2014
|
74 |
2 |
p. 257-265
|
article
|
| 21 |
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
|
Dragovich, T.
|
|
2014
|
74 |
2 |
p. 379-387
|
article
|
| 22 |
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody–drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates
|
Lu, Dan
|
|
2014
|
74 |
2 |
p. 399-410
|
article
|
| 23 |
Role of pregnane X receptor in chemotherapeutic treatment
|
Zhuo, Wei
|
|
2014
|
74 |
2 |
p. 217-227
|
article
|
| 24 |
Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis
|
Rani, Isha
|
|
2014
|
74 |
2 |
p. 309-322
|
article
|
| 25 |
Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients
|
Honoré, Per Hartvig
|
|
2014
|
74 |
2 |
p. 349-357
|
article
|
Journal description